We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 12 start-ups with an aggregate funding of $1.3b. The average funding per company in this subset is $108.6m.
Last update to the database: Feb 18, 2025. See changelog.
Small Molecules
4
Funding Rounds
$270.0m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
3
Funding Rounds
$50.6m
Money raised
Concerto Health AI is a Boston-based company which provides data and AI-driven solutions to life science researchers and healthcare providers.
1
Funding Rounds
$150.0m
Money raised
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.
4
Funding Rounds
$249.5m
Money raised
OncoDNA is a Gosselies-based medical diagnostics company developing diagnostic products for cancer treatment.
3
Funding Rounds
$49.7m
Money raised
Cedilla Therapeutics is a company founded in 2018.
4
Funding Rounds
$256.2m
Money raised
Known Medicine is a tool for oncologists to find the best treatment for cancer patients
1
Funding Rounds
$7.2m
Money raised
Pangaea Oncology is a biotechnology company based in Barcelona, Spain founded in 2007.
1
Funding Rounds
$12.0m
Money raised
A company that develops 3D cell-based models for drug response profiling
2
Funding Rounds
$3.0m
Money raised
Non-degrading, molecular
1
Funding Rounds
$90.0m
Money raised
Diagnostics
1
Funding Rounds
$90.0m
Money raised
Personal Genome Disgnostics is a Baltimore-based company.
1
Funding Rounds
$75.0m
Money raised